Women's Health Solutions
A dedicated focus on advancing women’s health through partnership, empathy, and scientific rigor.

At Syneos Health, we’re deeply committed to supporting biopharmaceutical industries developing innovative solutions in women’s health. Our teams bring together clinical, scientific and regulatory expertise to design and deliver thoughtful, reliable women’s health clinical trials that honor the needs of patients, sites and sponsors. We provide comprehensive women's health clinical research services that help sponsors navigate the complexities of CRO women’s health trials with clarity, compassion and operational excellence. We approach every program with the belief that successful studies start with listening—understanding your goals, your science, and the people at the heart of your research.
Contact our Women’s Health team to begin planning your next women’s health clinical trial.
Our women's health experience:
200+
women's health professionals
46,800
patients
5,240
sites
Our Approach: Collaborative, Nimble, Patient Centered
Women’s health trials require sensitivity, precision and genuine partnership. As a trusted women’s health drug development CRO, our therapeutically aligned experts work closely with you to shape study designs, anticipate complexities and bring forward practical solutions. There is never a “one size fits all” plan—each protocol receives tailored considerations, from endpoints to recruitment strategies, built around the lived experience of participants and the goals of your team.
We also draw on an integrated network of clinical and commercial subject matter experts, ensuring your program benefits from perspectives across disciplines—particularly valuable in areas like pregnancy studies, vaccine development, oncology and reproductive health. This cross functional collaboration enables seamless coordination and supports strong study outcomes across phase I-IV women’s health trials.

Therapeutic Focus Areas
- Endometriosis: We support trials that address chronic pain, quality of life and functional endpoints, using cycle-aware planning and validated patient reported outcome measures to honor the lived experience of women.
- Uterine fibroids: Our teams help sponsors design and operationalize studies focused on bleeding reduction, anemia outcomes and symptom relief, supported by imaging and global site networks.
- Polycystic ovary syndrome (PCOS): From metabolic parameters to ovulatory endpoints, we guide study designs that reflect the heterogeneity of PCOS and the needs of diverse patient populations.
- Gynecologic pain disorders: For conditions like dysmenorrhea or vulvodynia, we apply sensitive, patient-centered assessment methods and retention strategies.
- Female infertility/reproductive medicine: With experience across IVF, adjunctive treatments and emerging fertility technologies, we partner with sites and specialists who support patients through deeply personal journeys.
- Menopause/vasomotor symptoms (VMS): We operationalize trials measuring vasomotor symptoms, sleep disruption and daily functioning using tools that reduce burden and promote robust, consistent reporting.
Our women’s oncology teams work across the full disease spectrum with compassion and scientific clarity, supporting studies that address meaningful outcomes for patients and caregivers.
- Breast cancer: We bring experience across subtypes and treatment modalities, supported by deep site relationships and operational models that encourage engagement and care.
- Ovarian cancer, endometrial cancer, cervical cancer: We help sponsors navigate complex safety considerations, biomarker integration and diverse treatment pathways, grounded in strong collaboration with investigators.
- Pregnancy-related conditions: Our teams bring forward experience in prenatal vaccine trials, pregnancy safety studies and maternal health programs, supported by OB‑GYN leadership and specialized processes to protect maternal and fetal well‑being.
We support endometriosis, uterine fibroids, menopause/VMS, PCOS, female infertility, gynecologic pain disorders and cancers including breast, ovarian, endometrial and cervical, plus pregnancy related conditions—supported by integrated women's health clinical research services delivered by an experienced women’s health CRO.
We combine trusted site relationships with inclusive outreach, flexible visit design and supportive communication, ensuring each participant feels respected and informed throughout their journey in women’s health clinical trials.
Our in house OB/GYN physicians, experienced project teams and cross functional collaboration give sponsors a partner who understands the nuances of women’s health research and adapts to the needs of each study—including the sensitive operational demands of women's health clinical trial management across phase I IV women’s health trials.


